arrow
F

Francesca Ferlenghi

university of parma
H指数:13
被引数:469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models

靶向葡萄糖神经酰胺合酶在奥希替尼耐药的NSCLC细胞模型中诱导抗增殖和促凋亡作用

2024-03-181
OAAI
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl) isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization
2023-01-017
OAAI
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph-Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice

代谢软点和药代动力学: 以胆汁酸核心为特征的eph-ephrin拮抗剂的C-3位置的功能化是获得小鼠口服生物利用度的有效策略

2021-12-283
OAAI
A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine

磺酰氟衍生物通过催化赖氨酸的共价修饰抑制EGFRL858R/T790M/C797S

2021-12-0132
PREAI
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo (vol 63, pg 7369, 2020)
2020-09-282
PREAI
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo
2020-06-0922
PREAI
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties

基于石胆酸核心的EphA2拮抗剂的优化导致了UniPR505的鉴定,UniPR505是一种具有抗血管生成特性的新型3 α-氨基甲酰氧基衍生物

2020-03-016
PREAI